Helus Pharma Inc. Common Stock HELP

$11.80 +10.07% at last close

Recent SEC Filings

FormDescriptionFiledDocument
6-K 6-K 2026-10-08 View →
6-K FORM 6-K 2026-10-05 View →
6-K 6-K 2026-10-02 View →
4 FORM 4 2026-10-01 View →
4 FORM 4 2026-10-01 View →
4 FORM 4 2026-10-01 View →
6-K 6-K 2026-10-01 View →
6-K 6-K 2026-09-23 View →
6-K 6-K 2026-09-22 View →
4 FORM 4 2026-09-21 View →
6-K 6-K 2026-09-21 View →
4 FORM 4 2026-09-11 View →
4 FORM 4 2026-09-11 View →
4 FORM 4 2026-09-11 View →
6-K 6-K 2026-09-10 View →
4 FORM 4 2026-09-10 View →
4 FORM 4 2026-09-10 View →
4 FORM 4 2026-09-09 View →
6-K 6-K 2026-09-09 View →
4 FORM 4 2026-09-09 View →
6-K 6-K 2026-09-03 View →
6-K 6-K 2026-08-19 View →
6-K 6-K 2026-08-18 View →
6-K 6-K 2026-08-14 View →
6-K 6-K 2026-08-11 View →
6-K FORM 6-K 2026-08-03 View →
6-K 6-K 2026-07-21 View →
6-K FORM 6-K 2026-07-16 View →
6-K 6-K 2026-06-29 View →
6-K 6-K 2026-06-25 View →
6-K FORM 6-K 2026-06-25 View →
6-K 6-K 2026-06-11 View →
6-K 6-K 2026-06-01 View →
6-K 6-K 2026-05-04 View →
6-K 6-K 2026-04-30 View →
6-K 6-K 2026-04-28 View →
6-K 6-K 2026-04-23 View →
6-K 6-K 2026-04-20 View →
6-K 6-K 2026-04-20 View →
6-K 6-K 2026-04-16 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$11.80
Market Cap
$862.22 million
52-Week Range
$3.76 – $15.15
Average Volume
1.61 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.